Upcoming Events

The transformative potential of data and image analysis for eye care Apr 23, 2018 - Apr 24, 2018 — The Royal Society, Carlton House Terrace, London
Scottish Dementia Research Consortium Annual Conference 2018 Apr 23, 2018 10:00 AM - 04:00 PM — Radisson Blu, 301 Argyle St, Glasgow
British Cardiovascular Imaging 2018 May 02, 2018 - May 04, 2018 — John McIntyre Conference Centre, Edinburgh
2nd SINAPSE Psychology meeting May 08, 2018 10:30 AM - 04:00 PM — Yudowitz Seminar Room, Wolfson Medical Building, University of Glasgow
2nd PET is Wonderful International Meeting May 14, 2018 02:00 PM - 05:00 PM — Wellcome Auditorium/Fyfe Rooms, Queen’s Medical Research Institute, University of Edinburgh

PET3D PhD positions in Germany

Two PET imaging PhD positions open in PET3D training network

The EU project PET3D (PET Imaging in Drug Design and Development) is a new Innovative Training Network (ITN) funded (€4M) by the European Commission under the H2020 - MSCA-ITN-2015 programme, and coordinated by Professor Matteo Zanda at the University of Aberdeen.

PET3D is run by a Consortium of Universities and Industries operating in the Pharma sector with the aim to provide excellent, interdisciplinary and cross-sectorial training in Drug Design and Development within an innovative PhD programme for 15 Early Stage Researchers (ESRs).

All of the ESRs recruited by PET3D will be exposed to a variety of highly complementary research environments spanning different therapeutic areas: oncology, cardiovascular, neuroscience and all of the ESRs will spend at least one secondment in a different country and will have the opportunity to attend training events and consortium meetings in all of the 7 countries involved in PET3D.

Applications are now open for two positions at Westfaelische Wilhelms Universitaet Muenster (Germany):

PhD Fellow: ESR11 ‘Multi-modal and multi-tracer imaging of inflammation in stroke. Secondment: 6 months at IMANOVA, Sweden (month 12)

PhD Fellow: ESR12 ‘Multimodal two-photon microscopy and PET/MR imaging of glioma growth & angiogenesis’. Secondment: 6 months at AstraZenaca, UK (month 6)

For details of these positions, go to http://www.abdn.ac.uk/pet3d/recruitment/esr11/

The deadline for application is 15 February 2017.